Cover Image
市場調查報告書

老年性黃斑部病變:全球臨床實驗檢討

Age Related Macular Degeneration Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 232272
出版日期 內容資訊 英文 488 Pages
訂單完成後即時交付
價格
Back to Top
老年性黃斑部病變:全球臨床實驗檢討 Age Related Macular Degeneration Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月30日 內容資訊: 英文 488 Pages
簡介

本報告提供全球老年性黃斑部病變治療藥臨床實驗的相關調查,彙整各地區,Phase別,各狀態臨床實驗趨勢,正在開發的藥物概要等,為您概述為以下內容。

目錄

簡介

  • 老年性黃斑部病變
  • 報告指南

臨床試驗:各地區

  • 臨床試驗:各國
    • 對臨床實驗有所貢獻的前五國 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美
    • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
    • 對臨床實驗有所貢獻的前幾名國家 - 中南美

臨床試驗 G7各國

臨床試驗 G7各國,Phase別

臨床試驗 G7各國,各臨床實驗狀態

臨床試驗 E7各國

臨床試驗 E7各國,Phase別

臨床試驗 E7各國,各臨床實驗狀態

臨床試驗 Phase別

  • 進行中的臨床實驗:Phase別

臨床試驗:各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

  • 主要參與臨床實驗的企業

潛力治療藥物

  • 臨床試驗簡介
  • 臨床試驗概要:前幾名企業
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • Bayer AG
    • Regeneron Pharmaceuticals,Inc.
    • QLT Inc.
    • Ophthotech Corp.
    • GlaxoSmithKline plc
    • Allergan,Inc.
    • Valeant Pharmaceuticals International, Inc.
  • 臨床試驗概要:最高級大學 / 研究機關 / 醫院
    • National Eye Institute
    • Medical University of Vienna
    • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
    • Manhattan Eye Ear & Throat Hospital
    • Johns Hopkins University
    • U.S. Department of Veterans Affairs
    • Lawson Health Research Institute
    • Vitreous-Retina-Macula Consultants of New York
    • University of California,Davis
    • 京都大學

5件主要臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二次調查
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3808CTIDB

GlobalData's clinical trial report, "Age Related Macular Degeneration Global Clinical Trials Review, H2, 2016" provides an overview of Age Related Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Age Related Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Age Related Macular Degeneration Therapeutics Clinical Trials 28
  • Prominent Drugs 30
  • Latest Clinical Trials News on Age Related Macular Degeneration 31
  • Sep 13, 2016: Allergan Showcases Commitment to Eye Care Innovation with New Data Presentations at the Retina Society 49th Annual Scientific Meeting in San Diego 31
  • Clinical Trial Profile Snapshots 32

Appendix 485

  • Abbreviations 485
  • Definitions 485
  • Research Methodology 486
  • Secondary Research 486
  • About GlobalData 487
  • Contact Us 487
  • Disclaimer 487
  • Source 488

List of Tables

  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
  • Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2016* 21
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
  • Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

List of Figures

  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
  • Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
  • Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
  • GlobalData Methodology 486
Back to Top